» Articles » PMID: 26553931

AMIGO2, a Novel Membrane Anchor of PDK1, Controls Cell Survival and Angiogenesis Via Akt Activation

Abstract

The phosphoinositide 3-kinase-Akt signaling pathway is essential to many biological processes, including cell proliferation, survival, metabolism, and angiogenesis, under pathophysiological conditions. Although 3-phosphoinositide-dependent kinase 1 (PDK1) is a primary activator of Akt at the plasma membrane, the optimal activation mechanism remains unclear. We report that adhesion molecule with IgG-like domain 2 (AMIGO2) is a novel scaffold protein that regulates PDK1 membrane localization and Akt activation. Loss of AMIGO2 in endothelial cells (ECs) led to apoptosis and inhibition of angiogenesis with Akt inactivation. Amino acid residues 465-474 in AMIGO2 directly bind to the PDK1 pleckstrin homology domain. A synthetic peptide containing the AMIGO2 465-474 residues abrogated the AMIGO2-PDK1 interaction and Akt activation. Moreover, it effectively suppressed pathological angiogenesis in murine tumor and oxygen-induced retinopathy models. These results demonstrate that AMIGO2 is an important regulator of the PDK1-Akt pathway in ECs and suggest that interference of the PDK1-AMIGO2 interaction might be a novel pharmaceutical target for designing an Akt pathway inhibitor.

Citing Articles

Specific enhancer elements modulate phenotype plasticity and drug resistance in melanoma.

DeGeorgia S, Kaufman C bioRxiv. 2025; .

PMID: 39764051 PMC: 11702536. DOI: 10.1101/2024.12.12.628224.


AMIGO2 characterizes cancer-associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes.

Yong Y, Demmler R, Zohud B, Fang Q, Zhang T, Zhou Y J Pathol. 2024; 265(1):14-25.

PMID: 39523830 PMC: 11638658. DOI: 10.1002/path.6363.


AMIGO2 enhances the invasive potential of colorectal cancer by inducing EMT.

Izutsu R, Osaki M, Seong H, Ogata S, Sato R, Hamada J Cancer Gene Ther. 2024; 31(12):1786-1795.

PMID: 39379686 DOI: 10.1038/s41417-024-00842-z.


Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets.

Safder I, Valentine H, Uzzo N, Sfakianos J, Uzzo R, Gupta S JCO Precis Oncol. 2024; 8:e2300661.

PMID: 39151107 PMC: 11371085. DOI: 10.1200/PO.23.00661.


Role of AMIGO2 in cancer progression: Novel insights (Review).

Tian Z, Zhou D, Jiang R, Zhou B Oncol Lett. 2024; 28(3):434.

PMID: 39049987 PMC: 11268087. DOI: 10.3892/ol.2024.14567.


References
1.
Maroulakou I, Oemler W, Naber S, Tsichlis P . Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res. 2007; 67(1):167-77. DOI: 10.1158/0008-5472.CAN-06-3782. View

2.
Primo L, di Blasio L, Roca C, Droetto S, Piva R, Schaffhausen B . Essential role of PDK1 in regulating endothelial cell migration. J Cell Biol. 2007; 176(7):1035-47. PMC: 2064087. DOI: 10.1083/jcb.200607053. View

3.
Dimmeler S, Zeiher A . Akt takes center stage in angiogenesis signaling. Circ Res. 2000; 86(1):4-5. DOI: 10.1161/01.res.86.1.4. View

4.
Bonifazi P, DAngelo C, Zagarella S, Zelante T, Bozza S, De Luca A . Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol. 2009; 3(2):193-205. DOI: 10.1038/mi.2009.130. View

5.
Fujio Y, Walsh K . Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem. 1999; 274(23):16349-54. PMC: 3624707. DOI: 10.1074/jbc.274.23.16349. View